Acute and Chronic Toxicity Studies of Aqueous Extract from Helicteres isora (L.) Fruits in Animal Models

Main Article Content

Praw Suppajariyawat
Tiyanee Sahad
Wijittra Sudhong
Sutjarit Aunkat
Phatiphan Primpai
Nathaphat Harnkit
Sarayut Radapong
Sekrachatakorn Buabao
Taweesak Songserm
Pornchai Sincharoenpokai

Abstract

Helicteres isora (L.) is a medicinal herb recognized for its beneficial properties and popularity in health care and disease treatment. It has been developed into various commercial products; however, safety data regarding its extracts remain limited. This research aimed to evaluate the safety of an aqueous extract of H. isora. Acute toxicity testing in mice showed no acute toxic effects, with an LD50 value greater than 5,000 mg/kg. Chronic toxicity was assessed in rats through oral administration of the extract at doses of 112.5, 225, 450, 900, and 900-R mg/kg/day for 180 consecutive days. The results indicated that all doses of the extract did not cause abnormalities in general health or food consumption. Regarding hematological parameters, female rats receiving the extract at 225, 450, and 900-R mg/kg/day exhibited a statistically significant increase in mean corpuscular hemoglobin concentration (MCHC) compared to the control group. In terms of clinical chemistry, male rats administered the extract at doses ranging from 225 to 900 mg/kg/day showed a statistically significant decrease in serum potassium levels. Furthermore, female rats in the 900-R mg/kg/day dose group exhibited significantly elevated alkaline phosphatase (ALP) levels compared to the control group. Histopathological examination revealed some changes in liver, but these were not significantly different from the control group. The study concluded that the H. isora extract does not induce severe chronic toxicity. However, these findings suggest that caution should be advised for its use in individuals with certain pre-existing medical conditions.

Article Details

How to Cite
Suppajariyawat, P., Sahad, T., Sudhong, W., Aunkat, S. ., Primpai, P. ., Harnkit, N. ., Radapong, S. . ., Buabao, S., Songserm, T. ., & Sincharoenpokai, P. . (2025). Acute and Chronic Toxicity Studies of Aqueous Extract from Helicteres isora (L.) Fruits in Animal Models. Thai Journal of Toxicology, 40(1), 74–92. retrieved from https://li01.tci-thaijo.org/index.php/ThaiJToxicol/article/view/267577
Section
Research Articles

References

ประชาชาติธุรกิจ. ธุรกิจสมุนไพรไทย มูลค่าตลาดรวมปี 2566 แตะ 8.72 แสนล้านบาท [อินเตอร์เน็ต]. 2567 [เข้าถึงเมื่อ 5 พ.ค. 2568]. เข้าถึงได้จาก: https://www.prachachat.net/economy/news-1642555

กรุงเทพธุรกิจ. ตลาดสมุนไพรโต 6 หมื่นล้านบาท ดันสมุนไพรสู่ Soft power ส่งออก [อินเตอร์เน็ต]. [เข้าถึงเมื่อ 1 พ.ค. 2568]. เข้าถึงได้จาก: https://www.bangkokbiznews.com/health/well-being/1114148

กนกวรรณ ศันสนะพงษ์ปรีชา. การพัฒนายาสมุนไพรจากทรัพยากรธรรมชาติของประเทศ NAC2023.สำนักงานพัฒนาวิทยาศาสตร์และเทคโนโลยีแห่งชาติ. 28-31 มีนาคม 2566; การประชุมวิชาการประจำปี สวทช. ครั้งที่ 18. 2566. 1-23.

World Health Organization (WHO). Diabetes. Available at https://www.who.int/news-room/fact-sheets/detail/diabetes, accesses on May 2, 2025.

Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271–81.

Division of Non-Communicable Diseases, Department of Disease Control. annual report 2023.ministry of public health; 2023.

Department of Disease Control (DDC) reveals global diabetes situation, 537 million people have been diagnosed, contributing to 6.7 million deaths, or1death every 5 seconds. Office of the permanent secretary, ministry of public health; 2022.

The plant list. Malvaceae. Available at http://www.theplantlist.org/tpl1.1/search?q=helicteres+isora, accessed on April 28, 2025.

Botanical Garden Organization (BGO) Plant Databases, Ministry of Natural Resources and Environment. Available at http://www.qsbg.org/ database/botanic_book%20full%20option/search_detail.asp?botanic_id=2509, accessed on April 29, 2025

Haynes RR, Landolt E, Phengklai C, et al. Flora of Thailand Vol. 7, part 3, Alismataceae, Aponogetona-ceae, Ctenolophonaceae, Cymodoceaceae, Hamame-lidaceae, Hydrocharitaceae, Lemnaceae, Limnocha-ritaceae, Melastomataceae, Polygalaceae, Potamogeto-naceae, Sterculiaceae. Bangkok: The forest herbarium, royal forest department; 2001. p. 568.

Tang Y, Gilbert MG, Dorr LJ. Helicteres. in: flora of China vol. 12. 2007. p. 318.

Kumar N, Kumar SA. Plant profile, phytoche-mistry and pharmacology of Avartani (Helicteres isora Linn.): a review. Asian Pac J Trop Biomed 2014; 4 (Suppl 1): S22-6.

Boopathy RA, Elanchezhiyan C, Sethupathy S. Antihyperlipidemic activity of Helicteres isora fruit extract on streptozotocin induced diabetic male wistar rats. Eur Rev Med Pharmacol Sci 2010; 14: 191-6.

Kumar G, Banu GS, Murugesan AG. Influence of Helicteres isora administration for diabetes mellitus: The effect on changes in tissue fatty acid composition. Food Chem Toxicol 2009; 47(8): 1826-30.

Kumar G, Sharmila BG, Murugesan AG, et al. Preliminary toxicity and phytochemical studies of aqueous bark extract of Helicteres isora L. Int J Pharm 2007; 3(1): 96-100.

OECD Guideline for testing of chemicals. Guidance document on acute oral toxicity testing (No.423). Available at https://www.oecd.org/en/ publications/2002/02/test-no-423-acute-oral-toxicity-acute-toxic-class-method_g1gh294f.html, accessed on March 10, 2025.

OECD Guideline for testing of chemicals. Chronic toxicity studies, (No.452). Available at https:// www.oecd.org/en/publications/2018/06/test-no-452-chronic-toxicity-studies_g1gh2957.html, accessed on March 1, 2025.

Suppajariyawat P, Aunkat S, Sudhong W, et al. Investigation of Mutagenic Activity of Helicteres isora L. Extract. J Thai Trad Alt Med 2020; 18(3): 548-59.

Thai pharmacopoeia. Ministry of public health; department of medical sciences. Nonthaburi. 2003; 2: part 3.

Thai pharmacopoeia. Ministry of public health; department of medical sciences. Nonthaburi. 2003; 1: part 1

Prommuak C, De-Eknamkul W, Shotiprik A. Extraction of flavonoids and carotenoids from Thai silk waste and antioxidant activity of extracts. Sep Purif Technol 2008; 62: 444–8.

Veras KS, Fachel FNS, Pittol V, et al. Compatibility study of rosmarinic acid with excipients used in pharmaceutical solid dosage forms using thermal and non-thermal techniques. Saudi Pharm J 2019; 27(8): 1138-45.

United Nations. Globally harmonized system of classification and labelling of chemicals (GHS) Seventh revised edition. 2017.

Giang TT, Nhu LPQ, Ben TT, et al. Hepatopro-tective activity of Helicteres isora ethanol extract against paracetamol-induced liver injury in mice. Biosci Biotechnol Res Commun 2021; 14(4): 1468-72.

Soni D, Joshi R, Patel H, et al. Evaluation of Helicteres isora for its anti-inflammatory and anti-convulsant activities. Adv Pharmacol Pharm 2025; 13(1): 1-9.

Fletcher J. MCHC: Causes, treatment, and symptoms. Available at https://www.medical-newstoday.com/articles/321303, accessed on March 8, 2025.

Castro D, Sharma S. Hypokalemia. [Updated 2025 Jan 19]. In: Statpearls treasure island (FL): statpearls Publishing; 2025 Jan. Available at: https://www.ncbi.nlm.nih.gov/books/NBK482465/, accessed on March 1, 2025.

Kim HK, Kim SS. Electrical storm induced by hypokalemia associated with herbal medicines containing licorice. Transl Clin Pharmacol 2019; 27(2): 69-72.

Hayat B, Khan MA, Shah SWA, et al. Pre-clinical safety profile and behavioral effects of Helicteres isora Linn in an animal model. J Biol Regul Homeost Agents 2023; 37(11): 6231-45.

Giknis MLA, Clifford CB. Neoplastic and non-neoplastic lesions in the charles river wistar hannover [Crl:WI(Han)] rat. Available at file:///C:/Users/April/Downloads/Neoplastic%20and%20NonNeoPlastic%20Lesions%20in%20the%20Charles%20River%20Wistar%20Hannover%20[Crl-WI(Han)]%20Rat%20-%20March%2020 11.pdf, accessed on June 15, 2025.